Rhythm Pharmaceuticals, Inc. RYTM Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rhythm Pharmaceuticals, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s net income?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported net income of -$55.64M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s net income changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s net income decreased by 12.4% year-over-year, from -$49.5M to -$55.64M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s net income?
- Over 4 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s net income has grown at a 29.6% compound annual growth rate (CAGR), from -$69.61M to -$196.54M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.